Triple S Management Corporation (GTS)

Common Stock

35.99  +0.37 (+1.04%)

After market: 35.98 -0.01 (-0.03%)

Fundamental Rating

2

GTS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. GTS has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, GTS is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year GTS was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 2.54%
ROE 7.98%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin and Gross Margin are not available for GTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 1.97%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

GTS has less shares outstanding than it did 1 year ago.
GTS has a better debt/assets ratio than last year.

2.2 Solvency

A Debt/Equity ratio of 0.05 indicates that GTS is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

5

3. Growth

3.1 Past

GTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.55%.
GTS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.39% yearly.
Looking at the last year, GTS shows a quite strong growth in Revenue. The Revenue has grown by 16.10% in the last year.
GTS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.95% yearly.
EPS 1Y (TTM)-49.55%
EPS 3Y22.18%
EPS 5Y18.39%
EPS growth Q2Q-32.79%
Revenue 1Y (TTM)16.1%
Revenue growth 3Y8.28%
Revenue growth 5Y4.95%
Revenue growth Q2Q9.72%

3.2 Future

GTS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.09% yearly.
Based on estimates for the next years, GTS will show a quite strong growth in Revenue. The Revenue will grow by 8.03% on average per year.
EPS Next Y74.89%
EPS Next 2Y6.2%
EPS Next 3Y4.09%
EPS Next 5YN/A
Revenue Next Year6.28%
Revenue Next 2Y8.25%
Revenue Next 3Y8.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.17, GTS is valued on the expensive side.
GTS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
GTS is valuated reasonably with a Price/Forward Earnings ratio of 9.67.
When comparing the Price/Forward Earnings ratio of GTS to the average of the S&P500 Index (20.72), we can say GTS is valued rather cheaply.
Industry RankSector Rank
PE 21.17
Fwd PE 9.67

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.28
PEG (5Y)1.15
EPS Next 2Y6.2%
EPS Next 3Y4.09%

0

5. Dividend

5.1 Amount

No dividends for GTS!.
Industry RankSector Rank
Dividend Yield 0%

Triple S Management Corporation

NYSE:GTS (1/31/2022, 7:10:42 PM)

After market: 35.98 -0.01 (-0.03%)

35.99

+0.37 (+1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap856.20M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 21.17
Fwd PE 9.67
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.28
PEG (5Y)1.15
Profitability
Industry RankSector Rank
ROA 2.54%
ROE 7.98%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 1.97%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-49.55%
EPS 3Y22.18%
EPS 5Y
EPS growth Q2Q
EPS Next Y74.89%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.1%
Revenue growth 3Y8.28%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y